Search
Collplant Biotechnologies Ltd
CLGNAdd to Watchlist
0.340USD
-0.009-2.63%
Close 07/02, 13:00（ET）Quotes delayed by 15 min
4.36MMarket Cap
LossP/E TTM
Revenue Breakdown
Currency: USDUpdated: Mon, Apr 6
Currency: USDUpdated: Mon, Apr 6
FY2025
FY2025Q2
FY2024
FY2024Q2
FY2023
FY2023Q2
FY2022
FY2022Q2
FY2021
FY2020
FY2019
By BusinessUSD
Name
Revenue
Proportion
Revenues from licensing agreement
2.00M
84.35%
Revenues from the sales of goods
371.00K
15.65%
By RegionUSD
Name
Revenue
Proportion
United States
2.18M
91.78%
Europe
98.00K
4.13%
Canada
96.00K
4.05%
Israel
1.00K
0.04%
By Business
By Region
By BusinessUSD
Name
Revenue
Proportion
Revenues from licensing agreement
2.00M
84.35%
Revenues from the sales of goods
371.00K
15.65%